BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 14651434)

  • 1. Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment.
    Pontari MA
    Drugs Aging; 2003; 20(15):1111-25. PubMed ID: 14651434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic prostatitis: management strategies.
    Murphy AB; Macejko A; Taylor A; Nadler RB
    Drugs; 2009; 69(1):71-84. PubMed ID: 19192937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
    Magistro G; Wagenlehner FM; Grabe M; Weidner W; Stief CG; Nickel JC
    Eur Urol; 2016 Feb; 69(2):286-97. PubMed ID: 26411805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
    Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC
    BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.
    Franco JV; Turk T; Jung JH; Xiao YT; Iakhno S; Garrote V; Vietto V
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012551. PubMed ID: 29372565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy strategies in chronic prostatitis/chronic pelvic pain syndrome management.
    Murphy AB; Nadler RB
    Expert Opin Pharmacother; 2010 Jun; 11(8):1255-61. PubMed ID: 20429665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic prostatitis/chronic pelvic pain syndrome.
    Nickel JC
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1(Supplement 1):S112-6. PubMed ID: 17954024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management.
    Luzzi GA
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):253-6. PubMed ID: 12195565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis.
    Cohen JM; Fagin AP; Hariton E; Niska JR; Pierce MW; Kuriyama A; Whelan JS; Jackson JL; Dimitrakoff JD
    PLoS One; 2012; 7(8):e41941. PubMed ID: 22870266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of efficacy of different combination therapies of α-receptor blockers and traditional Chinese medicine external therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome: Bayesian network meta-analysis.
    Zhang K; Zhang Y; Hong S; Cao Y; Liu C
    PLoS One; 2023; 18(4):e0280821. PubMed ID: 37079509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of alpha1-blockers in chronic prostatitis syndromes.
    Nickel JC
    BJU Int; 2008 Mar; 101 Suppl 3():11-6. PubMed ID: 18307680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D; Wang P; Chen J; Wang S; Jiang H
    Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.
    Alexander RB; Propert KJ; Schaeffer AJ; Landis JR; Nickel JC; O'Leary MP; Pontari MA; McNaughton-Collins M; Shoskes DA; Comiter CV; Datta NS; Fowler JE; Nadler RB; Zeitlin SI; Knauss JS; Wang Y; Kusek JW; Nyberg LM; Litwin MS;
    Ann Intern Med; 2004 Oct; 141(8):581-9. PubMed ID: 15492337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy.
    Polackwich AS; Shoskes DA
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):132-8. PubMed ID: 26951713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
    Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M
    Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review.
    Franco JVA; Turk T; Jung JH; Xiao YT; Iakhno S; Garrote V; Vietto V
    BJU Int; 2019 Aug; 124(2):197-208. PubMed ID: 30019814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment.
    Watanabe T; Inoue M; Sasaki K; Araki M; Uehara S; Monden K; Saika T; Nasu Y; Kumon H; Chancellor MB
    BJU Int; 2011 Jul; 108(2):248-51. PubMed ID: 20883485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, pharmacologic considerations, and management of prostatitis.
    Schiller DS; Parikh A
    Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.